- Datum28.10.2025
- Uhrzeit18:00 - 19:00 Uhr
- Veranstalter
stock3
AbCellera Biologics Inc. Chart

Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren

Echtzeit-News zu diesem und anderen Unternehmen findest Du hier!
Live-Ticker AbCellera Biologics Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
4,39 %
Intraday
-2,23 %
1 Woche
16,53 %
1 Monat
94,88 %
Seit Jahresbeginn
105,40 %
1 Jahr
-44,62 %
3 Jahre
Passender Service zu AbCellera Biologics Inc.
Webinar zu AbCellera Biologics Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,891-6,515
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von AbCellera Biologics Inc.
Keine Dividenden verfügbar
Termine von AbCellera Biologics Inc.
- Nov6AbCellera Biologics Inc.Q3 2025 Earnings Release
- Feb24AbCellera Biologics Inc.Q4 2025 Earnings Release
- Mai7AbCellera Biologics Inc.Q1 2026 Earnings Release
Beschreibung
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
